In many cancer cell lines in vitro, ABT-737 at moderate doses causes little overt apoptosis on its own, but it can be used to trigger low-level (sub-lethal) caspase- and CAD activation (Ichim et al, 2015). This evidence concerns the gene CAD and cancer.